Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 134 (RNA5SP134) is classified as a pseudogene that closely resembles the functional 5S ribosomal RNA gene but lacks protein-coding capability due to mutations or sequence differences[2][4].\nPseudogenes like RNA5SP134 arise from duplication or retrotransposition and generally do not produce functional RNAs or proteins. While the parental gene (5S rRNA) plays an essential structural role in ribosomes by bridging functional centers within the ribosome and facilitating translation[1][3][5], the RNA5SP134 pseudogene itself is considered nonfunctional and is not a direct therapeutic target. In a broader context, some pseudogenes can exert regulatory effects (e.g., via acting as miRNA sponges or modulating expression of related genes)[4], but there is no specific evidence that RNA5SP134 fulfills such roles. Thus, it is mainly of interest for genomic annotation and evolutionary studies rather than as a functional or druggable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 134 (RNA5SP134).